Portfolio company
D-Nome
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Reme-D
This company develops molecular diagnostic kits for human and animal diseases to support healthcare providers and researchers in underserved regions.
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
StatDx
This company develops point-of-care molecular diagnostic systems for healthcare providers to identify infectious diseases and critical care conditions.
Delve Bio
This company provides metagenomic next-generation sequencing tests and diagnostic software to clinicians and laboratories for identifying pathogens in infectious diseases.
DiNona
This company develops monoclonal antibody therapies and rapid diagnostic kits for medical researchers, healthcare providers and pharmaceutical organisations.
Magnomics
This company develops portable molecular diagnostic devices using microfluidics and magnetoresistive technology to detect pathogens for human health, veterinary and food industry customers.
Inbiome
Inbiome develops molecular diagnostic platforms for rapid bacterial identification to support healthcare providers, pharmaceutical companies and military medical units in treating infections.
4BASES
This company develops diagnostic genetic testing kits and sequencing reagents for healthcare professionals and clinical laboratories to support precision medicine and disease prevention.
